U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807826) titled 'A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)' on Sept. 02.
Brief Summary: This is a multi-center, randomized, double blind, placebo-controlled Phase III study to evaluate the efficacy and safety of CM512, and to observe the life quality of subjects, the Pharmacokinetics, Pharmacodynamics and immunogenicity of CM512 in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP)
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Intervention:
BIOLOGICAL: CM512
subcutaneous injection
DRUG: Placebo
subcutaneous...